170 related articles for article (PubMed ID: 21119540)
21. Unexpected clinical remission of cholestasis after rifampicin therapy in patients with normal or slightly increased levels of gamma-glutamyl transpeptidase.
Cançado EL; Leitão RM; Carrilho FJ; Laudanna AA
Am J Gastroenterol; 1998 Sep; 93(9):1510-7. PubMed ID: 9732934
[TBL] [Abstract][Full Text] [Related]
22. Progressive familial intrahepatic cholestasis.
Jacquemin E
J Gastroenterol Hepatol; 1999 Jun; 14(6):594-9. PubMed ID: 10385071
[TBL] [Abstract][Full Text] [Related]
23. [Studies on the clinical manifestation and SLC25A13 gene mutation of Chinese patients with neonatal intrahepatic cholestasis caused by citrin deficiency].
Xing YZ; Qiu WJ; Ye J; Han LS; Xu SS; Zhang HW; Gao XL; Wang Y; Gu XF
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Apr; 27(2):180-5. PubMed ID: 20376801
[TBL] [Abstract][Full Text] [Related]
24. Cross-Sectional Analysis of Progressive Familial Intrahepatic Cholestasis in Puerto Rican Children.
Soler DM; Del Valle AI; Fernandez-Lube D; Shneider BL
P R Health Sci J; 2016 Dec; 35(4):220-223. PubMed ID: 27898169
[TBL] [Abstract][Full Text] [Related]
25. Phenotypic variability in Tunisian PFIC3 patients harboring a complex genotype with a differential clinical outcome of UDCA treatment.
Khabou B; Mahjoub B; Barbu V; Balhoudi N; Wardani A; Sfar MT; Fakhfakh F
Clin Chim Acta; 2018 Nov; 486():122-128. PubMed ID: 30036524
[TBL] [Abstract][Full Text] [Related]
26. Progressive familial intrahepatic cholestasis type 1 and extrahepatic features: no catch-up of stature growth, exacerbation of diarrhea, and appearance of liver steatosis after liver transplantation.
Lykavieris P; van Mil S; Cresteil D; Fabre M; Hadchouel M; Klomp L; Bernard O; Jacquemin E
J Hepatol; 2003 Sep; 39(3):447-52. PubMed ID: 12927934
[TBL] [Abstract][Full Text] [Related]
27. [Byler's disease (familial fibrogenic cholestasis in children). Apropos of 7 cases].
Razemon-Pinta M; Lecomte-Houcke M; Mary JP; Loreille GA
Pediatrie; 1988; 43(4):361-70. PubMed ID: 3419880
[TBL] [Abstract][Full Text] [Related]
28. ABCB4 mutations in adult patients with cholestatic liver disease: impact and phenotypic expression.
Degiorgio D; Crosignani A; Colombo C; Bordo D; Zuin M; Vassallo E; Syrén ML; Coviello DA; Battezzati PM
J Gastroenterol; 2016 Mar; 51(3):271-80. PubMed ID: 26324191
[TBL] [Abstract][Full Text] [Related]
29. Fifteen years single center experience in the management of progressive familial intrahepatic cholestasis of infancy.
Wanty C; Joomye R; Van Hoorebeek N; Paul K; Otte JB; Reding R; Sokal EM
Acta Gastroenterol Belg; 2004; 67(4):313-9. PubMed ID: 15727074
[TBL] [Abstract][Full Text] [Related]
30. Novel splice-site mutation in ATP8B1 results in atypical progressive familial intrahepatic cholestasis type 1.
Copeland E; Renault N; Renault M; Dyack S; Bulman DE; Bedard K; Otley A; Magee F; Acott P; Greer WL
J Gastroenterol Hepatol; 2013 Mar; 28(3):560-4. PubMed ID: 23033845
[TBL] [Abstract][Full Text] [Related]
31. Effects of ursodeoxycholic acid on intrahepatic cholestasis in rats.
Li L; Xu X; Lu F; Zhao N
Chin Med J (Engl); 2003 Jul; 116(7):1099-103. PubMed ID: 12890392
[TBL] [Abstract][Full Text] [Related]
32. [Idiopathic ductopenia of adulthood: favorable effect of ursodeoxycholic acid therapy].
Hartmann H; Gröne HJ
Z Gastroenterol; 1993 Feb; 31 Suppl 2():131-3. PubMed ID: 7483697
[TBL] [Abstract][Full Text] [Related]
33. [Intrahepatic cholestasis of pregnancy].
Sentilhes L; Bacq Y
J Gynecol Obstet Biol Reprod (Paris); 2008 Apr; 37(2):118-26. PubMed ID: 18006244
[TBL] [Abstract][Full Text] [Related]
34. Clinical and genetic characterization of pediatric patients with progressive familial intrahepatic cholestasis type 3 (PFIC3): identification of 14 novel ABCB4 variants and review of the literatures.
Chen R; Yang FX; Tan YF; Deng M; Li H; Xu Y; Ouyang WX; Song YZ
Orphanet J Rare Dis; 2022 Dec; 17(1):445. PubMed ID: 36550572
[TBL] [Abstract][Full Text] [Related]
35. ABCB4 gene mutations and single-nucleotide polymorphisms in women with intrahepatic cholestasis of pregnancy.
Bacq Y; Gendrot C; Perrotin F; Lefrou L; Chrétien S; Vie-Buret V; Brechot MC; Andres CR
J Med Genet; 2009 Oct; 46(10):711-5. PubMed ID: 19584064
[TBL] [Abstract][Full Text] [Related]
36. MYO5B mutations cause cholestasis with normal serum gamma-glutamyl transferase activity in children without microvillous inclusion disease.
Gonzales E; Taylor SA; Davit-Spraul A; Thébaut A; Thomassin N; Guettier C; Whitington PF; Jacquemin E
Hepatology; 2017 Jan; 65(1):164-173. PubMed ID: 27532546
[TBL] [Abstract][Full Text] [Related]
37. [Ursodeoxycholic acid: an alternative in the treatment of chronic cholestasis].
Parés A; Rodés J
Gastroenterol Hepatol; 1996 Feb; 19(2):58-67. PubMed ID: 8616682
[No Abstract] [Full Text] [Related]
38. [Acute pancreatitis secondary to partial multidrug resistance 3 p-glycoprotein deficit].
Marcos Prieto HM; Pérez Corte D; Piñero Pérez MC; Revilla Morato MC; Mora Soler AM; Acosta Materán RV; Jiménez Jurado A; Calabuig Mazzola V; Rodríguez Pérez A
Gastroenterol Hepatol; 2016; 39(7):465-6. PubMed ID: 26242827
[No Abstract] [Full Text] [Related]
39. Nodular regenerative hyperplasia of the liver: a rare differential diagnosis of cholestasis with response to ursodeoxycholic acid.
Faust D; Fellbaum C; Zeuzem S; Dietrich CF
Z Gastroenterol; 2003 Mar; 41(3):255-8. PubMed ID: 12664346
[TBL] [Abstract][Full Text] [Related]
40. Progressive familial intrahepatic cholestasis in Malaysian patients--a report of five cases.
Lee WS; Chai PF; Looi LM
Med J Malaysia; 2009 Sep; 64(3):216-9. PubMed ID: 20527271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
